Patent · US Active

Antimicrobial protein specific to Staphylococcus aureus

US8232370B2 · kind B2 · utility

3Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2007
Grant dateJul 31, 2012
Priority date
Expiry dateNov 28, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2795/00022
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel bacteriophage-originated protein having antimicrobial activity, more precisely an antimicrobial protein originated from lytic bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage-originated antimicrobial protein as an active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.